Billing details

Your order

Product Subtotal
Effects of the COVID-19 pandemic on the number and characteristics of public drug program beneficiaries in Ontario, Canada  × 1 $40.00
Do faster drug approvals increase safety risks? Evidence from Canada and Europe 2003-2012.  × 1 $10.00
Subtotal $50.00
HST (13%) $6.50
Total $56.50
  • Pay via PayPal.

Your personal data will be used to process your order, support your experience throughout this website, and for other purposes described in our privacy policy.